Demetrius Lopes, MD

The views expressed here are my own and do not necessarily reflect those of @AdvocateHealth. Editor @neurovexchange, Organizing Committee @WLNCOfficial

[NeuroNews @NN_publishing]

"We have found a device that will be very effective when we know the right patients to treat," says Jeffrey Saver, disclosing the final results of the DISTALS RCT indicating beneficial effects with @Rapid__Medical's Tigertriever 13 device in MeVO stroke
#ESOC2026 @ESOstroke

[JNIS @JNIS_BMJ]

🧠🔬 Neuro-dedicated intravascular OCT is emerging as a promising tool for intracranial vascular imaging. By enabling microscopic, high-resolution visualization of vessel wall pathology and therapeutic devices, it may expand our understanding of cerebrovascular disease and improve neurointerventional diagnosis and treatment strategies. 📖 Read more (open access): https://t.co/uGur9YugEj
@Cure4Stroke @_AdnanSiddiqui @Fie0815 @vitorpereiraca

[Demetrius Lopes, MD @Cure4Stroke]

@JNIS_BMJ Great read !!!

[Demetrius Lopes, MD @Cure4Stroke]

@Fie0815 @svinsociety @NguyenThanhMD @esamaniego @eytanraz @drricardohanel Sorry I missed you … came for last day

[Jens Fiehler @Fie0815]

@DrSohaibQadri @_AdnanSiddiqui @Acandisgmbh @STateshimaMD @Cure4Stroke In REBOOT, yes. In general, likely yes.

[Jens Fiehler @Fie0815]

Positive 12M results in bailout PTA/Stenting in 🇨🇳REBOOT RCT. https://t.co/buTxIggXWS PTA/Stenting improved 1-year mRS (gOR, 1.34). Fewer stroke recurrences (4% vs. 13%). @_AdnanSiddiqui @Acandisgmbh @STateshimaMD @Cure4Stroke

[Methinks @MethinksAI]

🧠 #WorldStrokeDay reminds us that access to stroke care should never depend on geography.

At last week’s #WSC, @marcriboj, Boris Pabón & Santiago Ortega-Gutiérrez (@CerebrovascLab) discussed how AI can help expand access to life-saving care in low and middle income countries.

[Demetrius Lopes, MD @Cure4Stroke]

@Fie0815 @Ansaar_Rai @JonnyDowner1 @STateshimaMD @MajidiShahram @MokinMax @jildazz Can’t wait to listen to your amazing work
Leaves 🍁 are changing here too sooo beautiful and inspiring!!!

[Demetrius Lopes, MD @Cure4Stroke]

@visishs @Stryker_NV @SiemensHealth @STateshimaMD Nice pics . Photographer captured the moments perfectly

[Jens Fiehler @Fie0815]

Better done than perfect? Stop after TICI 2b 1st pass?TICI 2b 1st pass not worse than TICI 3 after 2nd or 3rd pass? https://t.co/MdFtFktrxW Another reperfusiology analysis from 🇩🇪 GSR (n=6,398) @AdamArthurMD @Cure4Stroke @TudorGJovin @MokinMax @_AdnanSiddiqui @WinkelmeierMD

[NeuroNews @NN_publishing]

.@Cure4Stroke asks: is it better to target specific treatments when building robotic systems, or create a system that can "do everything". @vitorpereiracan believes the latter is preferable, noting successful device manipulation is the main focus of studies assessing robots

[Demetrius Lopes, MD @Cure4Stroke]

https://t.co/yevomgYYKW

[Demetrius Lopes, MD @Cure4Stroke]

Attending #WLNC2026 will for sure add value to your INR practice. Educational Grant can make this possible apply now!!!

[Demetrius Lopes, MD @Cure4Stroke]

Attending #WLNC2026 will for sure add value to your INR practice. Educational Grant can make this possible apply now!!!

[Demetrius Lopes, MD @Cure4Stroke]

Thi is what’s happening… nos vemos em Portugal 5/2026

[Demetrius Lopes, MD @Cure4Stroke]

Shanghai great WLNC 2025 … Chicago broadcast clip …. See you in Portugal 2026

[NeuroNews @NN_publishing]

.@kanduhealth and @NeuroLutions announced recently that they have merged to form Kandu Inc—a company that “expects to set a new standard of care for stroke recovery” by combining BCI technology with personalised telehealth services
@Cure4Stroke
https://t.co/de2BUrc9Uz

[Demetrius Lopes, MD @Cure4Stroke]

https://t.co/DnLdXqA8dX